In agreement with our findings, treating colon cancer cells with a combination of the rat anti-CR-1 antibodies and conventional cytotoxic drugs (e.g., 5-fluorouracil, epirubicin, or cis-platinum) results in a more significant inhibition of tumor cell growth compared with treatment with a single agent alone [24]. Here, CR1 is linked to colonic neoplasm.